SAN FRANCISCO, Jan. 7, 2019 /PRNewswire/ — InsightRX, the leader in individualizing medicine at the point-of-care, announced that its CEO, Sirj Goswami, Ph.D., will be speaking at the 37^th Annual J.P. Morgan Health Conference in San Francisco. Dr. Goswami will be speaking tomorrow, Tuesday, January 8^th at 12:30pm as part of a panel on innovation in healthcare titled, “Where to Find the Must-Know New Technologies and Companies: Ideas and Approaches You Need To Know.”

The co-panelists will be renowned Artificial Intelligence Scientist and CEO of Amicus Brain Innovations Chitra Dorai, Ph.D., Professor and Vice Chair of Pathology and Laboratory Medicine at Medical College of Wisconsin Nathan Ledeboer, Ph.D., and Head of Johnson & Johnson Innovation Kate Merton, Ph.D. Ken Bahk, Ph.D., CEO of Lakewood Holdings, will be moderating the panel.

InsightRX is a venture-backed, privately held, precision medicine and digital therapeutics company.

ABOUT INSIGHTRX
InsightRX is a cloud-based platform for precision dosing and clinical analytics designed to individualize treatment at the point of care, improving outcomes and reducing costs. Its first product, a precision dosing platform, combines machine learning with quantitative pharmacology to enable data-driven decision making in healthcare. For more details, see www.insight-rx.com. The InsightRX platform integrates with EHRs to streamline care.

Media Inquiries:

David Carvel

207171@email4pr.com

(205) 351-0574

View original content to download multimedia:http://www.prnewswire.com/news-releases/insightrx-to-present-at-the-37th-annual-jp-morgan-healthcare-conference-300773364.html

SOURCE Insight RX, Inc.